BillionaireNet
Huijuan
Zhong Huijuan
Rank #117
CHINAHealthcarePharmaceuticals

Zhong Huijuan

Net Worth
$20.876B
+0.03% (24h)
Zhong Huijuan is a highly successful Chinese pharmaceutical executive and businesswoman, renowned as the founder, CEO, and chair of Hansoh Pharmaceutical. Born in April 1961, she is recognized as the world's richest self-made woman, with a net worth of $21.5 billion. Her journey began with a degree in chemistry from Jiangsu Normal University, followed by a career as a chemistry teacher. In 1995, Zhong transitioned into the pharmaceutical industry, founding Hansoh Pharmaceutical Group. The company has since become a major player, specializing in oncology, central nervous system diseases, and diabetes treatments, with the majority of revenue coming from innovative drugs. Her strategic vision and leadership have propelled Hansoh to significant revenue and market capitalization, solidifying her position as a leading figure in the healthcare industry and a source of inspiration for aspiring entrepreneurs.

The Full Dossier

Early Life

Zhong Huijuan was born in April 1961, in Lianyungang, Jiangsu Province, China. She graduated with a degree in chemistry from Jiangsu Normal University in July 1982. Following her graduation, she worked as a chemistry teacher at Yan'an Middle School in Lianyungang.

Rise to Success

In 1995, Zhong Huijuan made a significant career change when she left her teaching job to establish Jiangsu Hansoh Pharmaceutical. Initially, the company had a small team of about ten employees. Hansoh focused on developing treatments for various diseases, including cancer, infectious diseases, diabetes, and central nervous system disorders. By 1997, the company's revenue reached $4.5 million. Hansoh Pharmaceutical had its initial public offering on the Hong Kong Stock Exchange in June 2019, raising $1 billion. This event made Zhong the richest self-made woman in Asia, with a net worth of $10.5 billion. Zhong holds a 66% stake in Hansoh Pharmaceutical through the Sunrise Trust. Her wealth increased significantly in 2020 amid the COVID-19 pandemic.

Key Business Strategies

Zhong Huijuan's key business strategy involved a strong emphasis on research and development (R&D). Hansoh invested heavily in innovation, which distinguished it from other pharmaceutical companies in China. The company's R&D budget later grew to nearly 10% of revenue, an unusually high level for a Chinese pharmaceutical company. Hansoh also focused on developing original medicines, rather than just generics.

Philanthropy

While specific amounts of Zhong Huijuan's philanthropy are not available in the search results, her commitment to the pharmaceutical industry suggests potential contributions to healthcare-related causes.

Career Timeline

2019

Richest Self-Made Woman in Asia

Zhong became the richest self-made woman in Asia.

2019

IPO on Hong Kong Stock Exchange

Hansoh Pharmaceutical had its initial public offering, raising $1 billion.

1997

Revenue of $4.5 million

Hansoh Pharmaceutical reached $4.5 million in revenue.

1995

Founded Hansoh Pharmaceutical

Zhong left her teaching job to establish the pharmaceutical company.

1982

Graduated from Jiangsu Normal University

Zhong Huijuan earned a degree in chemistry.

Philanthropic Impact

Healthcare$XB

Healthcare-related initiatives

Information on specific amounts is unavailable.

Wealth Trajectory